Tissue Engineering and Regeneration: Technologies and Global Markets

  • ID: 3905354
  • Report
  • Region: Global
  • 200 Pages
  • BCC Research
1 of 6
The Global Market for Tissue Engineering and Regeneration is Expected to Reach $60.8 Billion by 2021 from $13.6 Billion in 2016, Rising at a CAGR of 34.9%

FEATURED COMPANIES

  • Athersys Inc.
  • Cerapedics Inc.
  • Co. Don AG
  • Cook Medical Inc.
  • Cryolife Inc.
  • Cytori Therapeutics Inc.
  • MORE

The global market for tissue engineering and regeneration is expected to reach $60.8 billion by 2021 from $13.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 34.9% from 2016 through 2021.

This Report Provides:

  • An overview of the global market for tissue engineering and regeneration, and related technologies.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on the specific drivers, trends, and challenges for different segments of the market.
  • Valuable insight into future trends, details on products, and information on therapies available in the field of tissue engineering.
  • Analysis of the competitive environments, including new and potential markets for novel therapies and treatments.
  • Profiles of major players in the industry.

This report covers all the revenues earned by the regeneration therapies. These therapies are extensively used to replace and regenerate the cells, genes and tissues in a patient’s body. The report considers revenue generated by the products, as well as services in the regenerative medicine market. The services include the tools, along with the cell and gene bank charges, where the cells and tissues are stored and treated properly pre- and post-experimentation and treatment. The report also covers the revenues earned by small molecules and biologics (drugs) that speed up the regeneration process. Other drug therapy revenues (e.g., painkillers, analgesics) that can be used along with regenerative therapy are not included in the report, as they do not contribute to cell or tissue regeneration. The report covers all the existing applications of the regenerative medicine therapy.

The global tissue engineering and regeneration market is primarily segmented by components, materials, applications and region. The tissue engineering and regenerative medicine component market is categorized into therapeutic products, tools, banks and services. These therapeutic products are further segmented into cell therapy, gene therapy, tissue engineering, and small molecules and biologics based on product type.

The therapeutic products are also categorized into synthetic materials, biologically derived materials, genetically engineered materials, and small molecules and biologics based on material. The report includes key technologies involved in regenerative medicine therapy. The study analyzes the clinical trials and patents conducted in respective regions. The report provides an in-depth analysis of the key companies operating in the global tissue engineering and regeneration market.

The market is segmented by region as North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Advanced Cell Technology, Arteriocyte, Athersys, Bioheart, BioMimetic Therapeutics, BioTissue Technologies, CeraPedics, Cook Biotech, CryoLife, Cytograft Tissue Engineering, Cytomedix, Cytori Therapeutics, Genzyme/Sanofi, Integra LifeSciences, International Stem Cell, LifeCell/Kinetic Concepts and Mesoblast.

Intended Audience

This report is intended for business development professionals, entrepreneurs, and other investment groups in order to fully understand and evaluate properly each segment in the tissue engineering and regeneration industry.  It provides companies with new insights into competitors’ positions and discusses new opportunities otherwise overlooked or less known to the public.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Athersys Inc.
  • Cerapedics Inc.
  • Co. Don AG
  • Cook Medical Inc.
  • Cryolife Inc.
  • Cytori Therapeutics Inc.
  • MORE

1: Introduction

  • Study Goals And Objectives
  • Scope Of The Report
  • Intended Audience
  • Source Of Information And Methodology

2: Executive Summary

  • Table Summary : Global Market For Tissue Engineering And Regeneration, By Region, Through 2021
  • Figure Summary : Global Market For Tissue Engineering And Regeneration, By Region, 2015-2021

3: Tissue Engineering And Regeneration Market Overview

  • Progress And Promises For Tissue Engineering Industry
  • Nanotechnology For Tissue Regeneration
  • Gene Therapies: The Future Of Tissue Engineering
  • Stem Cell Technologies Boon To Tissue Engineering
  • Government Regulations And Legislations
  • Biopriniting Technology In Regenerative Medicine
  • Porter's Five Forces Analysis Of Tissue Engineering And Regeneration Market
  • Clinical Trials
  • Market Dynamics

4: Tissue Engineering And Regeneration Market Analysis By Components

  • Cell Therapy
  • Stem Cell Therapy
  • Stem Cell Sources
  • Existing And Development-Stage Stem Cell Products
  • Tissue Vascularization
  • Cell Culturing
  • Small Molecules And Biologics
  • Small Molecules
  • Biologics
  • Tissue Engineering
  • Gene Therapy
  • Table 7 : Global Market For Tissue Engineering And Regeneration, By Components, Through 2021
  • Table 8 : Global Market For Tissue Engineering And Regeneration, By Therapeutic Product, Through 2021

5: Tissue Engineering And Regeneration Market Analysis By Material

  • Synthetic Materials
  • Scaffolds: Medical Poly Lactic Acid
  • Biologically Derived Materials
  • Genetically Engineered Materials
  • Small Molecules And Biologics
  • Table 14 : Global Market For Tissue Engineering And Regeneration, By Therapeutic Material, Through 2021

6: Tissue Engineering And Regeneration Market By Application

  • Tissue Engineering And Regenerative Medicine For Cardiovascular Disorders
  • Tissue Engineering And Regenerative Medicine For Oncology
  • Tissue Engineering And Regenerative Medicine For Dermatology
  • Tissue Engineering And Regenerative Medicine For Musculoskeletal Applications
  • Tissue Engineering And Regenerative Medicine For Wound Healing
  • Tissue Engineering And Regenerative Medicine For Ophthalmology
  • Tissue Engineering And Regenerative Medicine For Neurology
  • Tissue Engineering For Central Nervous System Diseases
  • Internal Organ Regeneration
  • Table 37 : Global Tissue Engineering And Regeneration Market, By Application, Through 2021

7: Tissue Engineering And Regeneration Market By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest Of World
  • Figure 6 : Regenerative Medicine Companies By Size And Region
  • Table 60 : Global Tissue Engineering And Regeneration Market, By Region, Through 2021

8: Competitive Landscape

  • Approval
  • Agreement, Expansion And Collaboration
  • Product Launches And Patent Approvals
  • Acquistions And Mergers
  • Figure 8 : Key Competitive Strategies, 2012-2016 -

9: Patent Analysis

  • Figure 13 : Globally Registered And Approved Patents, 2016
  • Figure 14 : U.S., Europe And Japan Registered And Approved Patents, 2012-2016
  • Figure 15 : U.S. Patent Analysis By Market Participant, 2011-2016
  • Figure 16 : U.S. Patent Analysis By Application, 2012-2016
  • Figure 17 : Europe Patent Analysis By Market Participant, 2011-2016
  • Figure 18 : Europe Patent Analysis By Application, 2011-2016
  • Figure 19 : Japan Patent Analysis By Application, 2011-2016
  • Figure 20 : Japan Patent Analysis By Market Participant, 2011-2016

10: Company Profiles

  • Arteriocyte Medical Systems Inc.
  • Athersys Inc.
  • Cerapedics Inc.
  • Co. Don AG
  • Cook Medical Inc.
  • Cryolife Inc.
  • Cytori Therapeutics Inc.
  • Genzyme Corp.
  • Kinetic Concepts Inc.
  • Mesoblast Ltd.
  • Nuo Therapeutics Inc. (Cytomedix Inc.)
  • Ocata Therapeutics Inc. (Astellas Pharma Inc.)
  • Organogenesis Inc. (Advanced Biohealing)
  • Orthopeutics L.P.
  • U.S. Stem Cell Inc. (Bioheart Inc.)
  • Vericel Corp. (Aastrom Biosciences Inc.)
  • Wright Medical Group N.V

List Of Tables

Summary Table : Global Market For Tissue Engineering And Regeneration, By Region, Through 2021
Table 1 : U.S. And European Differences In Regulatory Approval
Table 2 : Main Aspects Of Healthcare Provisions In Different Countries
Table 3 : U.S. Clinical Trials For Tissue Engineering, By Company, 2010-2016
Table 4 : Completed U.S. Clinical Trials Conducted For Tissue Engineering, 2004-2015
Table 5 : Terminated U.S. Clinical Trials, 2012-2018
Table 6 : European Clinical Trials Conducted For Tissue Engineering, 2009-2019
Table 7 : Global Market For Tissue Engineering And Regeneration, By Components, Through 2021
Table 8 : Global Market For Tissue Engineering And Regeneration, By Therapeutic Product, Through 2021
Table 9 : Global Cell Therapy Market, By Region, Through 2021
Table 10 : Projects And Their Assessment Stages
Table 11 : Global Small Molecules And Biologics Market, By Region, Through 2021
Table 12 : Global Tissue Engineering Market, By Region, Through 2021
Table 13 : Global Gene Therapy Market, By Region, Through 2021
Table 14 : Global Market For Tissue Engineering And Regeneration, By Therapeutic Material, Through 2021
Table 15 : Global Synthetic Material Market, By Type, Through 2021
Table 16 : Global Synthetic Material Market, By Region, Through 2021
Table 17 : Biodegradable Polymer Classification
Table 18 : Global Biodegradable Synthetic Polymer Market, By Region, Through 2021
Table 19 : Commercial Polymeric Scaffold Products
Table 20 : Global Scaffold Market, By Region, Through 2021
Table 21 : Global Artificial Vascular Graft Market, By Region, Through 2021
Table 22 : Global Hydrogel Technology Market, By Region, Through 2021
Table 23 : Global Biologically Derived Market, By Type, Through 2021
Table 24 : Global Biologically Derived Material Market, By Region, Through 2021
Table 25 : Global Biologically Derived Collagen Market, By Region, Through 2021
Table 26 : Global Biologically Derived Xenogenic Tissue Market, By Region, Through 2021
Table 27 : Global Genetically Engineered Material Market, By Type, Through 2021
Table 28 : Global Genetically Engineered Material Market, By Region, Through 2021
Table 29 : Global Deoxyribonucleic Acid Transfection Vector Market, By Region, Through 2021
Table 30 : Global Genetically Manipulated Cell Market, By Region, Through 2021
Table 31 : Global Three-Dimensional Polymer Technology Market, By Region, Through 2021
Table 32 : Global Transgenic Market, By Region, Through 2021
Table 33 : Global Fibroblast Market, By Region, Through 2021
Table 34 : Global Neural Stem Cell Market, By Region, Through 2021
Table 35 : Global Gene-Activated Matrix Market, By Region, Through 2021
Table 36 : Global Market For Small Molecules And Biologics, By Region, Through 2021
Table 37 : Global Tissue Engineering And Regeneration Market, By Application, Through 2021
Table 38 : Global Tissue Engineering And Regeneration Market For Cardiovascular Applications, By Region, Through 2021
Table 39 : Cell Therapies By Different Companies To Treat Cadiovasular Diseases
Table 40 : Global Tissue Engineering And Regeneration Market For Oncology Application, By Region, Through 2021
Table 41 : Global And U.S. Statistics For Skin Damage Medical Conditions, 2011
Table 42 : Acellular Skin Tissue-Engineered Products In The Market
Table 43 : Cellular Skin Tissue-Engineered Products In The Market
Table 44 : Global Tissue Engineering And Regeneration Market For Dermatology Application, By Region, Through 2021
Table 45 : Global Tissue Engineering And Regeneration Market For Musculoskeletal Applications, By Region, Through 2021
Table 46 : Orthopedic Diseases By Region: Key Facts
Table 47 : Bone Damage And Related Disease Statistics, 2011
Table 48 : Global Statistics For Cartilage Damage, 2007
Table 49 : In Vitro Versus In Vivo Skeletal Muscle Tissue Engineering
Table 50 : Global Tissue Engineering And Regeneration Market For Wound Healing Applications, By Region, Through 2021
Table 51 : Global Tissue Engineering And Regeneration Market For Ophthalmology Application, By Region, Through 2021
Table 52 : Global Tissue Engineering And Regeneration Market For Neurology Application, By Region, Through 2021
Table 53 : Global Statistics For Neurodegenerative Diseases, 2015
Table 54 : U.S. Statistics For Spinal Cord Injuries, 2015
Table 55 : Global Market For Other Applications, By Region, Through 2021
Table 56 : U.S. Statistics For Liver Failure, 2011
Table 57 : Artificial Liver Support Systems
Table 58 : U.S. Statistics For Pancreatic Cancer And Diabetes, 2010
Table 59 : U.S. Statistics For Kidney Diseases, 2013
Table 60 : Global Tissue Engineering And Regeneration Market, By Region, Through 2021
Table 61 : North American Commercialized Tissue Engineering Products
Table 62 : North American Tissue Engineering And Regeneration Market, By Components, Through 2021
Table 63 : U.S. Statistics For Skin Damage Conditions Requiring Wound Care, 2011
Table 64 : U.S. Statistics For Bone Damage And Related Diseases, 2010
Table 65 : U.S. Statistics For Cardiovascular Disease, 2014
Table 66 : Tissue Engineering Research Conducted As Per Different Universities
Table 67 : Tissue Engineering Products Offered By Different Companies
Table 68 : Canada Statistics For Cardiovascular Disease, 2014
Table 69 : Canada Statistics For Spinal Cord Injury, 2014
Table 70 : Mexico Statistics For Cardiovascular Disease, 2011-2014
Table 71 : Mexico Statistics For Other Diseases And Injuries, 2012
Table 72 : Tissue Engineering Firms, By Business Type, 2014
Table 73 : Tissue Engineering Firms In Few European Countries
Table 74 : European Tissue Engineering And Regeneration Market, By Components, Through 2021
Table 75 : Germany Statistics For Mortality Causes, 2013
Table 76 : Companies That Target Different Tissue Engineering Areas
Table 77 : Different Causes Of Death: U.K. Statistics, 2013
Table 78 : Companies That Target Different Tissue Engineering Areas
Table 79 : Companies That Target Different Tissue Engineering Areas
Table 80 : Statistics For Cost Of Bone Damage Repair And Related Disorders In Europe
Table 81 : Cardiovasular Disease Healthcare Cost, By Country, 2014
Table 82 : European Stem Cell Policies, By Country
Table 83 : European Companies Developing Products In Tissue Engineering And Regeneration For Central Nervous System Disorders And Injuries
Table 84 : Asia-Pacific Tissue Engineering And Regeneration Market, By Components, Through 2021
Table 85 : Global Statistics For Skin-Related Medical Conditions, 2014
Table 86 : Rest Of World Tissue Engineering And Regeneration Market, By Components, Through 2021
Table 87 : Global Statistics For Central Nervous System Disorders And Injuries, 2015
Table 88 : Key Approvals, 2012-2016
Table 89 : Key Announced Agreements, Expansions And Collaborations, 2012-2016
Table 90 : Key Announced Product Launches And Patent Approvals, 2012-2016
Table 91 : Key Announced Acquistions And Mergers, 2012-2016
Table 92 : Arteriocyte Medical Systems Inc.: Recent Developments
Table 93 : Athersys Inc. Financials, 2013-2015
Table 94 : Athersys Inc.: Recent Developments
Table 95 : Cerapedics Inc.: Recent Developments
Table 96 : Co.Don AG: Recent Developments
Table 97 : Cook Medical Inc.: Recent Developments
Table 98 : Cryolife Inc. Financials, 2013-2015
Table 99 : Cryolife Inc.: Recent Developments
Table 100 : Cytori Therapeutics Financials, 2013-2015
Table 101 : Cytori Therapeutics Inc.: Recent Developments
Table 102 : Genzyme Corp. Financials, 2013-2015
Table 103 : Genzyme: Recent Developments
Table 104 : Kinetic Concepts Inc.: Recent Developments
Table 105 : Mesoblast Ltd. Financials, 2013-2015
Table 106 : Mesoblast Ltd.: Recent Developments
Table 107 : Nuo Therapeutics Inc. Financials, 2013-2015
Table 108 : Nuo Therapeutics Inc.: Recent Developments
Table 109 : Advanced Cell Technology Inc.: Recent Developments
Table 110 : Organogenesis Inc.: Recent Developments
Table 111 : Orthopeutics: Recent Developments
Table 112 : U.S. Stem Cell Inc. Financials, 2013-2015
Table 113 : U.S. Stem Cell Inc.: Recent Developments
Table 114 : Vericel Corp. Financials, 2013-2015
Table 115 : Vericel Corp.: Recent Developments
Table 116 : Wright Medical Group N.V. Financials, 2013-2015
Table 117 : Wright Medical Technology Inc.: Recent Developments

List Of Figures

Summary Figure : Global Market For Tissue Engineering And Regeneration, By Region, 2015-2021
Figure 1 : Tissue Engineering Strategies
Figure 2 : Nanotechnology And Tissue Regeneration
Figure 3 : Porter’S Five Forces Model For Tissue Engineering And Regenerative Medicine Market
Figure 4 : Growth In Disease Treated Versus Clinical Trials, 2011-2016
Figure 5 : T-Cell Therapy Technique
Figure 6 : Regenerative Medicine Companies By Size And Region
Figure 7 : Pathway For Dissemination Of Regenerative Medicine
Figure 8 : Key Competitive Strategies, 2012-2016 -
Figure 9 : Approval Strategy By Company - , 2012-2016
Figure 10 : Agreement, Expansion And Collaboration Strategies By Company - , 2012-2016
Figure 11 : Product Launch And Patent Approval Strategies By Company - , 2012-2016
Figure 12 : Acquistions And Mergers Strategies By Company - , 2012-2016
Figure 13 : Globally Registered And Approved Patents, 2016
Figure 14 : U.S., Europe And Japan Registered And Approved Patents, 2012-2016
Figure 15 : U.S. Patent Analysis By Market Participant, 2011-2016
Figure 16 : U.S. Patent Analysis By Application, 2012-2016
Figure 17 : Europe Patent Analysis By Market Participant, 2011-2016
Figure 18 : Europe Patent Analysis By Application, 2011-2016
Figure 19 : Japan Patent Analysis By Application, 2011-2016
Figure 20 : Japan Patent Analysis By Market Participant, 2011-2016

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Athersys Inc.
  • Cerapedics Inc.
  • Co. Don AG
  • Cook Medical Inc.
  • Cryolife Inc.
  • Cytori Therapeutics Inc.
  • MORE

Analyst Credentials

Dr. Marianna Tcherpakov has more than 7 years of experience as a bench scientist specializing in the area of biochemistry, cell biology, and industrial assay development.  She has contributed to a number of scientific publications and holds several patents.  She has expertise as an assay development scientist and is familiar with different research field trends and probable future developments.

Note: Product cover images may vary from those shown
5 of 6
  • Arteriocyte Medical Systems Inc.
  • Athersys Inc.
  • Cerapedics Inc.
  • Co. Don AG
  • Cook Medical Inc.
  • Cryolife Inc.
  • Cytori Therapeutics Inc.
  • Genzyme Corp.
  • Kinetic Concepts Inc.
  • Mesoblast Ltd.
  • Nuo Therapeutics Inc. (Cytomedix Inc.)
  • Ocata Therapeutics Inc. (Astellas Pharma Inc.)
  • Organogenesis Inc. (Advanced Biohealing)
  • Orthopeutics L.P.
  • U.S. Stem Cell Inc. (Bioheart Inc.)
  • Vericel Corp. (Aastrom Biosciences Inc.)
  • Wright Medical Group N.V
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll